Vir Biotechnology, Inc. · NASDAQ:VIR
Sabatini Brent received 50,000 Vir Biotechnology, Inc. shares as an award (Form 4)
Traded Nov 15, 2026 · Filed Nov 16, 2026
On Nov 15, 2026, Sabatini Brent (SVP, Chief Accounting Officer) received 50,000 Vir Biotechnology, Inc. shares as an award under a trading plan, leaving 111,902 shares. Filed Nov 16, 2026 (Form 4).
- Awarded
- 50,000 shares
- Holding after
- 111,902 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 15, 2026 | Common Stock | Award | 50,000 | 111,902 | Direct |
Source
Download original · View original at SEC
Related
- Vir Biotechnology, Inc.
- Sabatini Brent
- Vir Biotechnology, Inc. shareholders
- Form 4 · Sabatini Brent · Jun 2, 2026
- Form 4 · Sawaf Aziz · Nov 16, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026
- Schedule 13D/A · Robert Nelsen · Nov 6, 2026
- Form 4 · de Verneuil Vanina · Nov 4, 2026
- Form 4 · Topalian Suzanne Louise · Oct 28, 2026